| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
08-16-2011, 10:07 AM
|
#1 | ||
|
|||
|
Member
|
FDA, Industry Reach Generic Drug Fee Agreement
The New York Times, Published August 16, 2011 U.S. regulators and generic drugmakers have reached a compromise agreement for a user-fee program that would require the companies to pay some $299 million in the first year to accelerate drug approvals. The Food and Drug Administration has been in negotiations with the generic drug industry since February to establish a user-fee program similar to one in place for brand-name drugs and medical devices. |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | VICTORIALOU (08-16-2011) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| How the drug industry distorts medicine and politics. | Parkinson's Disease | |||
| FDA To Strengthen Generic Drug Program...Streamline Generic Drug Approval Process | Parkinson's Disease | |||
FDA, Industry Reach Generic Drug Fee Agreement
Threaded Mode